Darrin Uecker Biography and Net Worth

Chief Technology Officer & Director of Pulse Biosciences

Darrin R. Uecker was appointed Pulse Biosciences Chief Technology Officer in September 2022, having previously served as the Company’s Chief Executive Officer & President since September 2015. Mr. Uecker has over 30 years of experience in the medical device field and is a named inventor on over 70 patents. Prior to Pulse Biosciences Mr. Uecker was the President and Chief Operating Officer of Progyny, Inc., Menlo Park, California, a company that developed Eeva™, the world’s first automated time-lapse system for embryo selection during in-vitro fertilization. Prior to that Mr. Uecker was the Chief Executive Officer and President and a Director of Gynesonics, Inc., Redwood City, California, a company that developed a novel medical device for the treatment of symptomatic uterine fibroids using ultrasound guided radiofrequency ablation. Mr. Uecker has served in a variety of executive level roles at CyberHeart, Inc., Conceptus, Inc., RITA Medical Systems, Inc., and Computer Motion, Inc. Mr. Uecker attended the University of California at Santa Barbara where he received a B.S. and M.S. in electrical and computer engineering.

What is Darrin Uecker's net worth?: The estimated net worth of Darrin Uecker is at least $1.63 million as of September 17th, 2025. Mr. Uecker owns 122,872 shares of Pulse Biosciences stock worth more than $1,630,511 as of December 4th. This net worth evaluation does not reflect any other assets that Mr. Uecker may own. Learn More about Darrin Uecker's net worth.
How do I contact Darrin Uecker?: The corporate mailing address for Mr. Uecker and other Pulse Biosciences executives is 3957 POINT EDEN WAY, HAYWARD CA, 94545. Pulse Biosciences can also be reached via phone at (510) 906-4600 and via email at [email protected]. Learn More on Darrin Uecker's contact information.
Has Darrin Uecker been buying or selling shares of Pulse Biosciences?: Darrin Uecker has not been actively trading shares of Pulse Biosciences over the course of the past ninety days. Most recently, Darrin Uecker sold 20,000 shares of the business's stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $16.21, for a transaction totalling $324,200.00. Following the completion of the sale, the chief technology officer now directly owns 122,872 shares of the company's stock, valued at $1,991,755.12. Learn More on Darrin Uecker's trading history.
Who are Pulse Biosciences' active insiders?: Pulse Biosciences' insider roster includes Kevin Danahy (CEO), Robert Duggan (Co-Chairman of the Board of Directors), Mitchell Levinson (Insider), Mitchell Levinson (Insider), and Darrin Uecker (Chief Technology Officer & Director). Learn More on Pulse Biosciences' active insiders.
Are insiders buying or selling shares of Pulse Biosciences?: In the last twelve months, Pulse Biosciences insiders bought shares 3 times. They purchased a total of 145,969 shares worth more than $2,429,935.92. In the last twelve months, insiders at the sold shares 8 times. They sold a total of 160,000 shares worth more than $2,667,380.00. The most recent insider tranaction occured on October, 2nd when insider Kevin Patrick Danahy sold 4,600 shares worth more than $85,238.00. Insiders at Pulse Biosciences own 74.6% of the company. Learn More about insider trades at Pulse Biosciences.
Information on this page was last updated on 10/2/2025.

Darrin Uecker Insider Trading History at Pulse Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/17/2025	Sell	20,000	$16.21	$324,200.00	122,872
9/15/2025	Sell	25,000	$15.77	$394,250.00	122,872
9/11/2025	Sell	25,000	$14.78	$369,500.00	122,872
6/12/2025	Sell	15,000	$16.40	$246,000.00	137,872

Darrin Uecker Buying and Selling Activity at Pulse Biosciences

Pulse Biosciences Company Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Today's Range

Now: $13.27

$13.16

$13.54

50 Day Range

MA: $16.18

$12.66

$19.94

2 Week Range

Now: $13.27

$12.56

$25.00

Volume

178,210 shs

Average Volume

171,476 shs

Market Capitalization

$899.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8